share_log

华仁药业(300110.SZ):膦甲酸钠注射液取得药品注册证书

Huaren Pharmaceutical (300110.SZ): Sodium phosphinate injection obtained pharmaceutical registration certificate.

Gelonghui Finance ·  Nov 5 03:34

On November 5th, Hua Ren Pharmaceutical (300110.SZ) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the "Sodium Phosphonoformate Injection". Sodium Phosphonoformate Injection is used for Cytomegalovirus Retinitis in AIDS patients and Acyclovir-resistant Herpes Simplex Virus cutaneous and mucous membrane infection in patients with immune function damage.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment